UB Paderborn / Katalog / Suche / in CDI

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

The New England journal of medicine, 2018-06, Vol.378 (26), p.2475-2485

2018

Link zum Volltext

Verfügbarkeit prüfen

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

The lancet respiratory medicine, 2015-05, Vol.3 (5), p.355-366

2015

Link zum Volltext

Verfügbarkeit prüfen

ARIA 2016 executive summary: Integrated care pathways for predictive medicine throughout the life cycle in Argentina

Revista alergia Mexico (Tecamachalco, Pueblo, Mexico : 1993), 2017-07, Vol.64 (3), p.298-308

2017

Link zum Volltext

Verfügbarkeit prüfen

Assessment of dupilumab in children with moderate‐to‐severe type 2 asthma with or without evidence of allergic asthma

Allergy (Copenhagen), 2023-08, Vol.78 (8), p.2157-2167

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2)

EClinicalMedicine, 2021-05, Vol.35, p.100847-100847, Article 100847

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of CRSwNP in Latin America: A multidisciplinary consensus from an expert working group

The World Allergy Organization journal, 2024-03, Vol.17 (3), p.100886-100886, Article 100886

2024

Link zum Volltext

Verfügbarkeit prüfen

Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2015-09, Vol.3 (5), p.734-742.e5

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma

The New England journal of medicine, 2021-10, Vol.385 (18), p.1656-1668

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

The Lancet (British edition), 2019-11, Vol.394 (10209), p.1638-1650

2019

Link zum Volltext

Verfügbarkeit prüfen

Allergic Rhinitis and Sexual Dysfunction

Current treatment options in allergy, 2017-03, Vol.4 (1), p.62-70

2017

Link zum Volltext

Verfügbarkeit prüfen

Translating Chronic Urticarial Guidelines to Clinical Practice: A Study Assessing How Allergists and Dermatologists Apply Guidelines Recommendations in Argentina

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB248-AB248

2017

Link zum Volltext

Verfügbarkeit prüfen

The use of systemic corticosteroids in asthma management in Latin American countries

The World Allergy Organization journal, 2023-04, Vol.16 (4), p.100760-100760, Article 100760

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis

Otolaryngology-head and neck surgery, 2008, Vol.138 (1), p.30-37

2008

Link zum Volltext

Verfügbarkeit prüfen

Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma

The New England journal of medicine, 2021-12, Vol.385 (24), p.2230-2240

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

The lancet respiratory medicine, 2022-01, Vol.10 (1), p.11-25

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthma

ERJ open research, 2023-09, Vol.9 (5), p.37

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologic Management of Allergic Rhinitis During Pregnancy

Current treatment options in allergy, 2017-03, Vol.4 (1), p.54-61

2017

Link zum Volltext

Verfügbarkeit prüfen

The Scope of Pharmacological and Clinical Effects of Modern Antihistamines, With a Special Focus on Rupatadine: Proceedings from a Satellite Symposium held at the 21st World Allergy Congress, Buenos Aires, December 8, 2009

The World Allergy Organization journal, 2010-04, Vol.3 (4 Suppl), p.S1-S16

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized placebo‐controlled phase 3 trials

Allergy (Copenhagen), 2022-04, Vol.77 (4), p.1231-1244

2022

Link zum Volltext

Verfügbarkeit prüfen

Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count

Journal of allergy and clinical immunology, 2022-05, Vol.149 (5), p.1711-1721.e6

2022

Link zum Volltext

Verfügbarkeit prüfen

Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

Annals of allergy, asthma, & immunology, 2021-05, Vol.126 (5), p.584-592.e1

2021

Link zum Volltext

Verfügbarkeit prüfen

Insights, attitudes, and perceptions about asthma and its treatment: findings from a multinational survey of patients from Latin America

The World Allergy Organization journal, 2013-11, Vol.6 (1), p.19-19, Article 19

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM study

Respiratory medicine, 2023-10, Vol.217, p.107334-107334, Article 107334

2023

Link zum Volltext

Verfügbarkeit prüfen

Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma

Advances in therapy, 2018-05, Vol.35 (5), p.737-748

2018

Link zum Volltext

Verfügbarkeit prüfen

Reslizumab Treatment for Moderate to Severe Asthma with Elevated Blood Eosinophil Levels

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB381-AB381

2015

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

ARIA 2016 executive summary: Integrated care pathways for predictive medicine throughout the life cycle in Argentina

Assessment of dupilumab in children with moderate‐to‐severe type 2 asthma with or without evidence of allergic asthma

Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2)

Management of CRSwNP in Latin America: A multidisciplinary consensus from an expert working group

Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Allergic Rhinitis and Sexual Dysfunction

Translating Chronic Urticarial Guidelines to Clinical Practice: A Study Assessing How Allergists and Dermatologists Apply Guidelines Recommendations in Argentina

The use of systemic corticosteroids in asthma management in Latin American countries

Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis

Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthma

Pharmacologic Management of Allergic Rhinitis During Pregnancy

The Scope of Pharmacological and Clinical Effects of Modern Antihistamines, With a Special Focus on Rupatadine: Proceedings from a Satellite Symposium held at the 21st World Allergy Congress, Buenos Aires, December 8, 2009

Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized placebo‐controlled phase 3 trials

Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count

Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

Insights, attitudes, and perceptions about asthma and its treatment: findings from a multinational survey of patients from Latin America

Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM study

Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma

Reslizumab Treatment for Moderate to Severe Asthma with Elevated Blood Eosinophil Levels

Suchergebnisse filtern